Real-time
Euronext Bruxelles
05:06:17 2024-05-07 am EDT
|
5-day change
|
1st Jan Change
|
22.34
EUR
|
+1.18%
|
|
+7.09%
|
-10.28%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,429
|
9,451
|
8,622
|
8,240
|
5,986
|
5,308
|
-
|
-
|
Enterprise Value (EV)
1 |
11,872
|
10,865
|
9,582
|
9,344
|
7,252
|
7,001
|
7,446
|
7,753
|
P/E ratio
|
36.4
x
|
72.8
x
|
14
x
|
14.5
x
|
15.6
x
|
14.3
x
|
13.5
x
|
14.4
x
|
Yield
|
1.73%
|
0.64%
|
2.24%
|
2.33%
|
3.21%
|
3.74%
|
3.84%
|
3.95%
|
Capitalization / Revenue
|
3.1
x
|
2.92
x
|
2.18
x
|
1.98
x
|
1.54
x
|
1.36
x
|
1.25
x
|
1.17
x
|
EV / Revenue
|
3.53
x
|
3.35
x
|
2.42
x
|
2.25
x
|
1.87
x
|
1.79
x
|
1.75
x
|
1.71
x
|
EV / EBITDA
|
15.8
x
|
13.5
x
|
7.66
x
|
8.12
x
|
7.46
x
|
7.51
x
|
7.6
x
|
7.48
x
|
EV / FCF
|
-236
x
|
79.4
x
|
9.69
x
|
65.4
x
|
45.9
x
|
-37.4
x
|
-50.4
x
|
-64.4
x
|
FCF Yield
|
-0.42%
|
1.26%
|
10.3%
|
1.53%
|
2.18%
|
-2.67%
|
-1.98%
|
-1.55%
|
Price to Book
|
4
x
|
3.7
x
|
2.77
x
|
2.34
x
|
1.63
x
|
1.37
x
|
1.3
x
|
1.28
x
|
Nbr of stocks (in thousands)
|
240,530
|
240,535
|
241,183
|
240,092
|
240,400
|
240,401
|
-
|
-
|
Reference price
2 |
43.36
|
39.29
|
35.75
|
34.32
|
24.90
|
22.08
|
22.08
|
22.08
|
Announcement Date
|
2/7/20
|
2/11/21
|
2/16/22
|
2/16/23
|
2/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,361
|
3,239
|
3,963
|
4,155
|
3,876
|
3,912
|
4,256
|
4,524
|
EBITDA
1 |
753
|
804
|
1,251
|
1,151
|
972
|
932
|
980.3
|
1,036
|
EBIT
1 |
509
|
536
|
971.4
|
865
|
674
|
605.2
|
642.3
|
639.2
|
Operating Margin
|
15.14%
|
16.55%
|
24.51%
|
20.82%
|
17.39%
|
15.47%
|
15.09%
|
14.13%
|
Earnings before Tax (EBT)
1 |
395.9
|
195.1
|
806
|
710
|
482
|
471.8
|
512.6
|
471.6
|
Net income
1 |
287.8
|
130.5
|
619
|
569.9
|
385
|
359.4
|
358.2
|
361.3
|
Net margin
|
8.56%
|
4.03%
|
15.62%
|
13.72%
|
9.93%
|
9.19%
|
8.42%
|
7.99%
|
EPS
2 |
1.190
|
0.5400
|
2.560
|
2.370
|
1.600
|
1.545
|
1.632
|
1.531
|
Free Cash Flow
1 |
-50.3
|
136.8
|
989
|
142.9
|
157.9
|
-187
|
-147.6
|
-120.3
|
FCF margin
|
-1.5%
|
4.22%
|
24.96%
|
3.44%
|
4.07%
|
-4.78%
|
-3.47%
|
-2.66%
|
FCF Conversion (EBITDA)
|
-
|
17.01%
|
79.06%
|
12.42%
|
16.24%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
104.83%
|
159.77%
|
25.07%
|
41.01%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.7500
|
0.2500
|
0.8000
|
0.8000
|
0.8000
|
0.8260
|
0.8482
|
0.8719
|
Announcement Date
|
2/7/20
|
2/11/21
|
2/16/22
|
2/16/23
|
2/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
1,726
|
1,564
|
1,675
|
2,150
|
1,814
|
2,148
|
2,093
|
2,067
|
1,809
|
2,018
|
1,971
|
EBITDA
1 |
396
|
376
|
429
|
762
|
489
|
601
|
550
|
519
|
453
|
489
|
453
|
EBIT
1 |
269
|
243
|
293
|
625
|
346.3
|
461
|
346
|
373
|
300
|
296.5
|
304.6
|
Operating Margin
|
15.59%
|
15.54%
|
17.49%
|
29.07%
|
19.09%
|
21.46%
|
16.53%
|
18.05%
|
16.58%
|
14.7%
|
15.45%
|
Earnings before Tax (EBT)
|
-
|
126.3
|
68.8
|
540
|
266
|
396
|
314
|
295.1
|
186.9
|
-
|
-
|
Net income
|
-
|
90.9
|
39.6
|
400
|
218.8
|
309.1
|
261
|
223
|
162
|
-
|
-
|
Net margin
|
-
|
5.81%
|
2.36%
|
18.6%
|
12.06%
|
14.39%
|
12.47%
|
10.79%
|
8.96%
|
-
|
-
|
EPS
|
0.5800
|
0.3800
|
0.1600
|
1.650
|
0.9000
|
1.280
|
1.090
|
0.9300
|
0.6700
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.2500
|
-
|
-
|
Announcement Date
|
2/7/20
|
7/31/20
|
2/11/21
|
7/30/21
|
2/16/22
|
7/29/22
|
2/16/23
|
7/28/23
|
2/16/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,443
|
1,414
|
960
|
1,104
|
1,266
|
1,693
|
2,138
|
2,445
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.916
x
|
1.759
x
|
0.7674
x
|
0.9592
x
|
1.302
x
|
1.816
x
|
2.181
x
|
2.36
x
|
Free Cash Flow
1 |
-50.3
|
137
|
989
|
143
|
158
|
-187
|
-148
|
-120
|
ROE (net income / shareholders' equity)
|
11.1%
|
12.5%
|
23.1%
|
17.9%
|
12.5%
|
9.98%
|
10.2%
|
9.57%
|
ROA (Net income/ Total Assets)
|
4.4%
|
4.19%
|
3.84%
|
6.25%
|
4.49%
|
3.4%
|
2.78%
|
3.09%
|
Assets
1 |
6,538
|
3,113
|
16,123
|
9,124
|
8,573
|
10,584
|
12,877
|
11,688
|
Book Value Per Share
2 |
10.80
|
10.60
|
12.90
|
14.60
|
15.20
|
16.10
|
16.90
|
17.20
|
Cash Flow per Share
2 |
1.980
|
2.190
|
5.220
|
2.630
|
4.340
|
2.840
|
2.950
|
3.220
|
Capex
1 |
588
|
392
|
389
|
491
|
885
|
829
|
866
|
827
|
Capex / Sales
|
17.49%
|
12.09%
|
9.82%
|
11.82%
|
22.83%
|
21.2%
|
20.35%
|
18.28%
|
Announcement Date
|
2/7/20
|
2/11/21
|
2/16/22
|
2/16/23
|
2/16/24
|
-
|
-
|
-
|
Last Close Price
22.08
EUR Average target price
24.39
EUR Spread / Average Target +10.46% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.33% | 5.72B | | +15.43% | 65.38B | | -1.42% | 47.8B | | +14.49% | 40.65B | | +23.50% | 26.69B | | +9.40% | 19.24B | | +2.39% | 17.75B | | -21.87% | 16B | | +1.52% | 15.23B | | -9.48% | 15.37B |
Other Specialty Chemicals
|